Immunocore Holdings IMCR
NASDAQ IMCR
$29.71 -0.83 (-2.72%)
At close: Oct 2, 2026 · 4:00 PM EDT

Immunocore Holdings (IMCR) Other Accumulated Expenses (2022 - 2024)

Updated

Immunocore Holdings' Other Accumulated Expenses came in at $7.46 million for Q1 2024, up 24.5% from the prior quarter.

Analysis

Immunocore Holdings (IMCR) Other Accumulated Expenses (2022 - 2024) Analysis & Trends

At the end of FY2023, Immunocore Holdings' Other Accumulated Expenses was $5.99 million, up 62.7% from FY2022.

  • Going back by year, Other Accumulated Expenses was $3.68 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Immunocore Holdings 1.53 Bn -1.95 Bn 114.84 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 7.46 Mn
Dec 31, 2023 5.99 Mn
Dec 31, 2022 3.68 Mn
API Access

Immunocore Holdings Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=IMCR&period=max&api_key=YOUR_API_KEY